Jelinek DF - Search Results

1

Age at diagnosis and the utility of prognostic testing in patients with chronic lymphocytic leukemia.

Shanafelt TD, Rabe KG, Kay NE, Zent CS, Jelinek DF, Reinalda MS, Schwager SM, Bowen DA, Slager SL, Hanson CA, Call TG. Shanafelt TD, et al. Among authors: jelinek df. Cancer. 2010 Oct 15;116(20):4777-87. doi: 10.1002/cncr.25292. Cancer. 2010. PMID: 20578179 Free PMC article.

2

Phase II trials of single-agent anti-VEGF therapy for patients with chronic lymphocytic leukemia.

Shanafelt T, Zent C, Byrd J, Erlichman C, Laplant B, Ghosh A, Call T, Villalona-Calero M, Jelinek D, Bowen D, Laumann K, Wu W, Hanson C, Kay N. Shanafelt T, et al. Leuk Lymphoma. 2010 Dec;51(12):2222-9. doi: 10.3109/10428194.2010.524327. Epub 2010 Nov 5. Leuk Lymphoma. 2010. PMID: 21054149 Free PMC article. Clinical Trial.

3

Chromosome anomalies detected by interphase fluorescence in situ hybridization: correlation with significant biological features of B-cell chronic lymphocytic leukaemia.

Dewald GW, Brockman SR, Paternoster SF, Bone ND, O'Fallon JR, Allmer C, James CD, Jelinek DF, Tschumper RC, Hanson CA, Pruthi RK, Witzig TE, Call TG, Kay NE. Dewald GW, et al. Among authors: jelinek df. Br J Haematol. 2003 Apr;121(2):287-95. doi: 10.1046/j.1365-2141.2003.04265.x. Br J Haematol. 2003. PMID: 12694251 Free article.

4

VEGF receptor phosphorylation status and apoptosis is modulated by a green tea component, epigallocatechin-3-gallate (EGCG), in B-cell chronic lymphocytic leukemia.

Lee YK, Bone ND, Strege AK, Shanafelt TD, Jelinek DF, Kay NE. Lee YK, et al. Among authors: jelinek df. Blood. 2004 Aug 1;104(3):788-94. doi: 10.1182/blood-2003-08-2763. Epub 2004 Mar 2. Blood. 2004. PMID: 14996703 Free article.

5

Fluorescent-labeled DNA probes applied to novel biological aspects of B-cell chronic lymphocytic leukemia.

Fink SR, Paternoster SF, Smoley SA, Flynn HC, Geyer SM, Shanafelt TD, Lee YK, Jelinek DF, Kay NE, Dewald GW. Fink SR, et al. Among authors: jelinek df. Leuk Res. 2005 Mar;29(3):253-62. doi: 10.1016/j.leukres.2004.07.012. Leuk Res. 2005. PMID: 15661260

6

Combination chemoimmunotherapy with pentostatin, cyclophosphamide, and rituximab shows significant clinical activity with low accompanying toxicity in previously untreated B chronic lymphocytic leukemia.

Kay NE, Geyer SM, Call TG, Shanafelt TD, Zent CS, Jelinek DF, Tschumper R, Bone ND, Dewald GW, Lin TS, Heerema NA, Smith L, Grever MR, Byrd JC. Kay NE, et al. Among authors: jelinek df. Blood. 2007 Jan 15;109(2):405-11. doi: 10.1182/blood-2006-07-033274. Epub 2006 Sep 28. Blood. 2007. PMID: 17008537 Free PMC article. Clinical Trial.

7

Prospective evaluation of clonal evolution during long-term follow-up of patients with untreated early-stage chronic lymphocytic leukemia.

Shanafelt TD, Witzig TE, Fink SR, Jenkins RB, Paternoster SF, Smoley SA, Stockero KJ, Nast DM, Flynn HC, Tschumper RC, Geyer S, Zent CS, Call TG, Jelinek DF, Kay NE, Dewald GW. Shanafelt TD, et al. Among authors: jelinek df. J Clin Oncol. 2006 Oct 1;24(28):4634-41. doi: 10.1200/JCO.2006.06.9492. J Clin Oncol. 2006. PMID: 17008705

8

Using smudge cells on routine blood smears to predict clinical outcome in chronic lymphocytic leukemia: a universally available prognostic test.

Nowakowski GS, Hoyer JD, Shanafelt TD, Geyer SM, LaPlant BR, Call TG, Jelinek DF, Zent CS, Kay NE. Nowakowski GS, et al. Among authors: jelinek df. Mayo Clin Proc. 2007 Apr;82(4):449-53. doi: 10.4065/82.4.449. Mayo Clin Proc. 2007. PMID: 17418074

9

Risk factors for development of a second lymphoid malignancy in patients with chronic lymphocytic leukaemia.

Maddocks-Christianson K, Slager SL, Zent CS, Reinalda M, Call TG, Habermann TM, Bowen DA, Hoyer JD, Schwager S, Jelinek DF, Kay NE, Shanafelt TD. Maddocks-Christianson K, et al. Among authors: jelinek df. Br J Haematol. 2007 Nov;139(3):398-404. doi: 10.1111/j.1365-2141.2007.06801.x. Br J Haematol. 2007. PMID: 17910629 Free article.

10

Immunoglobulin diversity gene usage predicts unfavorable outcome in a subset of chronic lymphocytic leukemia patients.

Tschumper RC, Geyer SM, Campbell ME, Kay NE, Shanafelt TD, Zent CS, Nowakowski GS, Call TG, Dewald GW, Jelinek DF. Tschumper RC, et al. Among authors: jelinek df. J Clin Invest. 2008 Jan;118(1):306-15. doi: 10.1172/JCI32625. J Clin Invest. 2008. PMID: 18064298 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

188 results

Search Page